Skip to main content
logo
Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.8480
-0.0258 (-2.95%)
At close: Sep 4, 2026, 4:00 PM EDT
0.9120
+0.0640 (7.55%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Akso Health Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Sep '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Market Capitalization
7261,95390595546842539017812017017
Market Cap Growth (YoY)
-22.56%359.39%131.95%435.95%290.72%150.55%2149.80%633.49%1398.03%--
Enterprise Value
7291,9447317813843413079512117119
Last Close Price
0.852.281.641.731.301.181.361.070.821.160.74

Price Ratios

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Sep '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Forward PE
-5.085.085.085.085.085.085.085.085.085.08
PS Ratio
52.52141.2263.1364.3231.6328.7733.5921.0722.0670.297.49
PB Ratio
4.0210.805.004.812.362.131.960.890.601.230.13
P/TBV Ratio
4.0210.805.005.292.602.362.162.021.361.230.13
P/FCF Ratio
-----415.76---125.59-
P/OCF Ratio
---131.57111.09361.20---125.59-
PEG Ratio
-0.510.510.510.510.510.510.510.510.510.51

EV Ratios

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Sep '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
EV/Sales Ratio
52.68140.5650.9852.5925.9223.0526.4411.2422.2270.658.30
EV/FCF Ratio
-----333.10---126.24-

Financial Efficiency

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Sep '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Debt / Equity Ratio
0.010.010.010.010.010.010.010.030.030.010.01
Debt / FCF Ratio
-----2.04---1.48-
Net Debt / Equity Ratio
0.010.010.01-0.05-0.05-0.87-0.87-0.42-0.42-0.60-0.60
Net Debt / EBITDA Ratio
-1.35-1.35-1.436.205.6098.21-----
Net Debt / FCF Ratio
-0.17-0.17-0.020.050.11-170.28122.4121.8867.24-61.55510.82
Asset Turnover
0.070.070.070.070.070.080.070.070.050.03-
Inventory Turnover
70.9270.9273.1075.2376.1678.9660.9211.497.352.44-
Quick Ratio
0.170.170.171.191.1912.8312.837.507.5023.7023.70
Current Ratio
21.7721.7721.771.531.5314.2014.208.198.1939.5239.52
Return on Equity (ROE)
-9.85%-9.85%-40.76%-68.29%-68.10%-80.26%-42.09%-6.41%-7.63%-12.38%-
Return on Assets (ROA)
-1.24%-1.24%-1.36%-1.42%-1.29%-1.37%-1.89%-3.73%-4.21%-6.64%-
Return on Invested Capital (ROIC)
-2.18%-2.18%-2.37%-2.55%-4.08%-15.69%-7.65%-5.92%-9.05%-15.63%-40.75%
Return on Capital Employed (ROCE)
-2.20%-2.20%-2.40%-2.40%-2.20%-2.00%-2.70%-3.40%-3.90%-6.20%-9.00%

Yields

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Sep '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Earnings Yield
-2.57%-0.96%-8.53%-14.21%-28.89%-31.75%-18.14%-3.70%-6.69%-5.57%-43.49%
FCF Yield
-1.76%-0.66%-10.01%-17.64%-17.87%0.24%-0.36%-2.17%-1.05%0.80%-0.94%
Buyback Yield / Dilution
-153.50%-153.50%-55.24%-204.20%-257.10%-504.37%-1475.88%-565.82%-949.18%-106.30%-53.20%
Total Shareholder Return
-153.50%-153.50%-55.24%-204.20%-257.10%-504.37%-1475.88%-565.82%-949.18%-106.30%-53.20%
SEC Filings: 10-K · 10-Q